47 related articles for article (PubMed ID: 15307876)
1. Enterocyte proliferation and signaling are constitutively altered in celiac disease.
Nanayakkara M; Lania G; Maglio M; Kosova R; Sarno M; Gaito A; Discepolo V; Troncone R; Auricchio S; Auricchio R; Barone MV
PLoS One; 2013; 8(10):e76006. PubMed ID: 24204586
[TBL] [Abstract][Full Text] [Related]
2. Outcome in pediatric celiac disease is independent of the diagnostic approach in patients with high antibody levels.
Klöti S; Schaad J; Spalinger J; Schibli S; Hart L; Sokollik C; Righini-Grunder F
J Pediatr Gastroenterol Nutr; 2024 May; ():. PubMed ID: 38769762
[TBL] [Abstract][Full Text] [Related]
3. Measured levels of positive transglutaminase 2 antibodies are not associated with presentation or incidental endoscopic findings at celiac disease diagnosis.
Katunin E; Aitokari L; Kivelä L; Ilus T; Huhtala H; Kaukinen K; Kurppa K
Scand J Gastroenterol; 2024 Apr; 59(4):419-424. PubMed ID: 38164975
[TBL] [Abstract][Full Text] [Related]
4. Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis.
Tornai T; Palyu E; Vitalis Z; Tornai I; Tornai D; Antal-Szalmas P; Norman GL; Shums Z; Veres G; Dezsofi A; Par G; Par A; Orosz P; Szalay F; Lakatos PL; Papp M
World J Gastroenterol; 2017 Aug; 23(29):5412-5421. PubMed ID: 28839442
[TBL] [Abstract][Full Text] [Related]
5. To screen or not to screen? Celiac antibodies in liver diseases.
Narciso-Schiavon JL; Schiavon LL
World J Gastroenterol; 2017 Feb; 23(5):776-791. PubMed ID: 28223722
[TBL] [Abstract][Full Text] [Related]
6. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases.
Sturgeon C; Fasano A
Tissue Barriers; 2016; 4(4):e1251384. PubMed ID: 28123927
[TBL] [Abstract][Full Text] [Related]
7. Serum I-FABP Detects Gluten Responsiveness in Adult Celiac Disease Patients on a Short-Term Gluten Challenge.
Adriaanse MP; Leffler DA; Kelly CP; Schuppan D; Najarian RM; Goldsmith JD; Buurman WA; Vreugdenhil AC
Am J Gastroenterol; 2016 Jul; 111(7):1014-22. PubMed ID: 27185075
[TBL] [Abstract][Full Text] [Related]
8. Application of Deamidated Gliadin Antibodies in the Follow-Up of Treated Celiac Disease.
de Chaisemartin L; Meatchi T; Malamut G; Fernani-Oukil F; Hosking F; Rault D; Bellery F; Cellier C; Dragon-Durey MA
PLoS One; 2015; 10(8):e0136745. PubMed ID: 26322980
[TBL] [Abstract][Full Text] [Related]
9. Anti-actin IgA antibodies identify celiac disease patients with a Marsh 3 intestinal damage among subjects with moderate anti-TG2 levels.
Schirru E; Danjou F; Cicotto L; Rossino R; Macis MD; Lampis R; Jores RD; Congia M
Biomed Res Int; 2013; 2013():630463. PubMed ID: 24083232
[TBL] [Abstract][Full Text] [Related]
10. Triggers and drivers of autoimmunity: lessons from coeliac disease.
Sollid LM; Jabri B
Nat Rev Immunol; 2013 Apr; 13(4):294-302. PubMed ID: 23493116
[TBL] [Abstract][Full Text] [Related]
11. Detection of autoantibodies against actin filaments in celiac disease.
Porcelli B; Ferretti F; Vindigni C; Scapellato C; Terzuoli L
J Clin Lab Anal; 2013 Jan; 27(1):21-6. PubMed ID: 23292801
[TBL] [Abstract][Full Text] [Related]
12. Celiac disease and immigration in Northeastern Italy: the "drawn double nostalgia" of "cozonac" and "panettone" slices.
Parco S; Città A; Vascotto F; Tamaro G
Clin Exp Gastroenterol; 2011; 4():121-5. PubMed ID: 21753894
[TBL] [Abstract][Full Text] [Related]
13. Cutting-edge issues in celiac disease and in gluten intolerance.
Bizzaro N; Tozzoli R; Villalta D; Fabris M; Tonutti E
Clin Rev Allergy Immunol; 2012 Jun; 42(3):279-87. PubMed ID: 21181303
[TBL] [Abstract][Full Text] [Related]
14. IgA anti-actin antibodies in children with celiac disease: comparison of immunofluorescence with Elisa assay in predicting severe intestinal damage.
Bazzigaluppi E; Parma B; Tronconi GM; Corsin P; Albarello L; Mora S; Barera G
Ital J Pediatr; 2010 Mar; 36():25. PubMed ID: 20298549
[TBL] [Abstract][Full Text] [Related]
15. Screening for celiac disease in Down's syndrome patients revealed cases of subtotal villous atrophy without typical for celiac disease HLA-DQ and tissue transglutaminase antibodies.
Uibo O; Teesalu K; Metskula K; Reimand T; Saat R; Sillat T; Reimand K; Talvik T; Uibo R
World J Gastroenterol; 2006 Mar; 12(9):1430-4. PubMed ID: 16552815
[TBL] [Abstract][Full Text] [Related]
16. Celiac disease: is the atypical really typical? Summary of the recent National Institutes of Health Consensus Conference and latest advances.
Gadewar S; Fasano A
Curr Gastroenterol Rep; 2005 Dec; 7(6):455-61. PubMed ID: 16313875
[TBL] [Abstract][Full Text] [Related]
17. Enterocyte actin autoantibody detection: a new diagnostic tool in celiac disease diagnosis: results of a multicenter study.
Clemente MG; Musu MP; Troncone R; Volta U; Congia M; Ciacci C; Neri E; Not T; Maggiore G; Strisciuglio P; Corazza GR; Gasbarrini G; Cicotto L; Sole G; Fasano A; De Virgiliis S
Am J Gastroenterol; 2004 Aug; 99(8):1551-6. PubMed ID: 15307876
[TBL] [Abstract][Full Text] [Related]
18. Determining IgA and IgG antigliadin, IgA antitransglutaminase, and antiendomysial antibodies in monkey esophagus and in umbilical cord for diagnosis of celiac disease in developing countries.
Bahia M; Penna FJ; Sampaio IB; Silva GM; Andrade EM
J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):551-8. PubMed ID: 18030232
[TBL] [Abstract][Full Text] [Related]
19. IgA anti-actin antibodies ELISA in coeliac disease: a multicentre study.
Carroccio A; Brusca I; Iacono G; Alessio MG; Sonzogni A; Di Prima L; Barrale M; Ottomano C; Ambrosiano G; Teresi S; D'Angelo A; Pirrone G; Cefalù B; Scalici C; La Chiusa SM
Dig Liver Dis; 2007 Sep; 39(9):818-23. PubMed ID: 17652043
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
